Compugen CGEN
NASDAQ CGEN
$2.09 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Compugen (CGEN) Change in Accrued Expenses (2009 - 2010)

Updated

Compugen (CGEN) recorded Change in Accured Expenses of $500,000 in FY2025, compared with -$2.69 million in FY2024.

Analysis

Compugen (CGEN) Change in Accrued Expenses (2009 - 2010) Analysis & Trends

Starting with FY2009, Compugen's Change in Accured Expenses history includes 17 years.

  • Annual Change in Accured Expenses has a five-year compound annual growth rate of -33.4% (FY2020 to FY2025).
  • Annual Change in Accured Expenses has ranged from -$2.69 million in FY2024 to $3.71 million in FY2021 over the past five years.
  • Per Business Quant data, CGEN's Change in Accured Expenses was -$2.69 million in FY2024, $1.46 million in FY2023, -$1.6 million in FY2022 and $3.71 million in FY2021 (-2.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Compugen 197.62 Mn -218.36 Mn 1.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 776,000.00
Sep 30, 2010 61,000.00
Dec 31, 2009 116,000.00
Sep 30, 2009 -224,000.00
API Access

Compugen Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CGEN&period=max&api_key=YOUR_API_KEY